Hiroyuki Gatanaga

9PUBLICATIONS
49CO-AUTHORS
Gene and molecular therapyInnate immunityClinical social work practicePharmacogenomicsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 14, 2026
VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

|Apr 23, 2026
Multistep coevolution of HIV-1 and human leukocyte antigen-C-restricted HIV-1-specific CD8+ T cells and the association with disease progression.

|Nov 12, 2025
HIV-1-specific CD8+ T cells with different abilities to recognize HIV-1-infected cells in HIV-1-exposed seronegative individuals.

Hung The Nguyen, Takayuki Chikata, Nozomi Kuse

|May 20, 2025
Doxycycline pre-exposure prophylaxis prevents sexually transmitted infections without affecting vaginal bacterial flora in female sex workers.

Seitaro Abe, Daisuke Mizushima, Naokatsu Ando

|Mar 13, 2025
Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial.

Jürgen K Rockstroh, Roger Paredes, Pedro Cahn

|Nov 14, 2023
Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial.

Naokatsu Ando, Daisuke Mizushima, Yosuke Shimizu

Pageof 2

Frequent Collaborators

4 joint publications

Naokatsu Ando

4 joint publications

Daisuke Mizushima

3 joint publications

Koji Watanabe

3 joint publications

Shinichi Oka